Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 8, 2026, 11:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 1,558 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Disease, Arrhythmias Clear all

Conditions: Atrial Fibrillation
Interventions: Placebo, Ramipril, Spironolactone; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 455 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sudden Cardiac Death, Sudden Cardiac Arrest
Interventions: Wearable Cardioverter Defibrillator; Device
Lead sponsor: Zoll Medical Corporation; Industry
Eligibility: 50 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 31
States / cities: Corona, California • Downey, California • Escondido, California + 28 more

Conditions: Solid Tumors
Interventions: AZD6094 200 mg, Placebo, Moxifloxacin; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Postural Tachycardia Syndrome
Interventions: Saline, Placebo; Drug · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation
Interventions: Pulmonary Vein Isolation procedure; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Atrial Fibrillation, Catheter Ablation, Pericarditis
Interventions: Colchicine; Drug
Lead sponsor: St. Vincent Cardiovascular Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Premature Atrial Contractions, Premature Ventricular Contractions
Interventions: Start: On Caffeine, Start: Off Caffeine; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Kidney Injury, Renal Insufficiency, Chronic, Heart Failure, Myocardial Infarction, Arrhythmias, Cardiac, Stroke
Interventions: Transcatheter Aortic Valve Replacement; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2031
U.S. locations: 3
States / cities: Dallas, Texas

Conditions: Dilated Cardiomyopathy (DCM)
Interventions: RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3); Genetic
Lead sponsor: Rocket Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: San Diego, California • Rochester, Minnesota • Charleston, South Carolina

Conditions: Atrial Fibrillation
Interventions: Cardioversion; Procedure
Lead sponsor: Creighton University; Other
Eligibility: 19 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Atrial Fibrillation, Risk Factors, Risk Reduction Behavior
Interventions: AliveCor mobile ECG cardiac monitor, AF Program, Standard of care; Other · Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ventricular Tachycardia, Cardiac Arrhythmia
Interventions: MRI scan; Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: Not listed
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Atrial Fibrillation
Interventions: radiofrequency catheter ablation; Procedure
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Bradycardia, Congestive Heart Failure
Interventions: EASYTRAK EPI lead; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Artificial Heart Valve
Interventions: Genotype-guided dose determination, Non-genotype guided warfarin dosing; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Atrial Fibrillation
Interventions: Conventional AF Ablation with PVI, FIRM-guided ablation plus PVI; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 22 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 2
States / cities: San Diego, California • Stanford, California

Conditions: Atrial Fibrillation
Interventions: AF CARE, Usual Care; Device · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pain
Interventions: Methadone HCl Inject 10 mg/ml (will require dilution), Methadone; Drug
Lead sponsor: University of Utah; Other
Eligibility: 29 Weeks to 48 Weeks
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Bradycardia
Interventions: CARDIX-101A, CARDIX-101B, CARDIX-101C; Drug
Lead sponsor: Cardix Therapeutics LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Atrial Fibrillation
Interventions: Patient Decision Support Tool; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Supraventricular Tachycardia
Interventions: Agitated saline push; Other
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: COPD, Arrhythmia, Murmur, Heart, Chronic Disease
Interventions: Coala Heart Monitor; Device
Lead sponsor: Coala Life, Inc; Industry
Eligibility: 65 Years and older
Enrollment: 100 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Linden, Tennessee

Conditions: Heart Block, Bradycardia, Tachycardia, Arrhythmia
Interventions: MP3; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 4 Years to 55 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Thrombosis Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 57,250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study

A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)

Second Study to Assess Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation

Post-Ablation Pericarditis Reduction Study

Coffee and Real-time Atrial and Ventricular Ectopy

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

Secondary Prevention of Atrial Fibrilation

MRI Assessment of Arrythmia Ablation Lesions

Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation

The EASYTRAK EPI Clinical Investigation

Genotype-Guided Warfarin Therapy Trial

Evaluation of Conventional Ablation With or Without Focal Impulse and Rotor Modulation to Eliminate Human AF

Feasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk Reduction

Methadone Pharmacokinetics and Cardiac Effects in Newborns

An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia

Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF

Simulation of Adenosine Push Methods for Treatment of SVT Using Agitated Saline Visualized by Ultrasound

Perry Virtual - A Prospective and Observational Rural Health Trial

iPod and Other MP3 Players on ICDs and Pacemakers in Children

Global Anticoagulant Registry in the Field